May 14 (Reuters)-
Trans Genic Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 11.05 11.05 12.00
(+0.0 pct) (+27.3 pct) (+8.6 pct)
Operating 893 mln 173 mln 1.20
(+414.0 pct) (-35.7 pct) (+34.3 pct)
Recurring 891 mln 94 mln 1.10
(+839.3 pct) (-63.0 pct) (+23.3 pct)
Net
Net 546 mln loss 440 mln 600 mln
(+9.8 pct)
EPS 31.45 yen loss 25.38 yen 34.55 yen
EPS Diluted 31.45 yen
Ann Div 3.00 yen NIL 3.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 3.00 yen NIL 3.00 yen
NOTE - Trans Genic Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2342.T